HEB - Hemispherx Biopharma, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 513M
Enterprise Value 311.59M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)31.78
Price/Book (mrq)1.06
Enterprise Value/Revenue 328.33
Enterprise Value/EBITDA 6-1.18

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Mar 31, 2018


Profit Margin 0.00%
Operating Margin (ttm)-2,625.43%

Management Effectiveness

Return on Assets (ttm)-40.52%
Return on Equity (ttm)-70.43%

Income Statement

Revenue (ttm)409k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)-33.30%
Gross Profit (ttm)-746k
Net Income Avi to Common (ttm)-8.15M
Diluted EPS (ttm)-0.2600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.64M
Total Cash Per Share (mrq)0.1
Total Debt (mrq)2.66M
Total Debt/Equity (mrq)26.09
Current Ratio (mrq)2.14
Book Value Per Share (mrq)0.26

Cash Flow Statement

Operating Cash Flow (ttm)-7.49M
Levered Free Cash Flow (ttm)-4.94M

Trading Information

Stock Price History

Beta 0.12
52-Week Change 3-23.51%
S&P500 52-Week Change 316.98%
52 Week High 30.6500
52 Week Low 30.2600
50-Day Moving Average 30.3006
200-Day Moving Average 30.3654

Share Statistics

Avg Vol (3 month) 3383.21k
Avg Vol (10 day) 3176.96k
Shares Outstanding 547.21M
Float 45.11M
% Held by Insiders 12.34%
% Held by Institutions 19.89%
Shares Short (Jul 13, 2018) 4458.13k
Short Ratio (Jul 13, 2018) 41.1
Short % of Float (Jul 13, 2018) 41.24%
Short % of Shares Outstanding (Jul 13, 2018) 40.99%
Shares Short (prior month Jun 15, 2018) 4511.22k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/12
Last Split Date 3Aug 29, 2016